Skip to main content
Signal8
Wang Jonathan Jian profile photo

Jonathan Jian Wang

CIK: 0001555242

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ImageneBio, Inc. logo
IMA

ImageneBio, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • ImageneBio, Inc. logo
    IMA

    ImageneBio, Inc.

    Jun 16, 2026
    Award(A)

    Stock Option (right to buy)

    Direct
    15.6K shares-
  • ImageneBio, Inc. logo
    IMA

    ImageneBio, Inc.

    Dec 18, 2025
    Award(A)

    Employee Stock Option (Right to Buy)

    Direct
    31.2K shares-
  • ImageneBio, Inc. logo
    IMA

    ImageneBio, Inc.

    Jul 25, 2025
    Award(A)
    Direct
    143.8K shares-
  • ImageneBio, Inc. logo
    IMA

    ImageneBio, Inc.

    Jul 25, 2025
    Award(A)
    Indirect
    971.2K shares-

1-4 of 4

About Wang Jonathan Jian

Wang Jonathan Jian (SEC CIK 0001555242) files insider reports with the SEC as Director of ImageneBio, Inc. (IMA).

Signal8 holds 4 ownership filings by Wang Jonathan Jian (1 Form 3, 3 Form 4), filed between Aug 15, 2025 and Jun 18, 2026. Those filings report 4 transactions, from Jul 25, 2025 to Jun 16, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Wang Jonathan Jian's filings is in SAN DIEGO, CA.

Recent filings by Wang Jonathan Jian

  • Jun 16, 2026: Grant or award of IMA derivative securities (Form 4, code A).
  • Dec 18, 2025: Grant or award of IMA derivative securities (Form 4, code A).
  • Jul 25, 2025: Grants or awards of IMA shares (2 lines, Form 4, code A).

Other insiders filing for ImageneBio, Inc. (IMA)

How to read Form 4 transaction codes